E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 6
7 / 6Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Original Research

Online Publishing Date:
14 / 11 / 2022

 


The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.

Utkarsh Patel, Mahendra Thakre, Dnyaneshwar Asole, P.P. Ashok.


Abstract
TITLE: The Utility of Plasma N- Terminal Brain Natriuretic Peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.
PURPOSE: To measure plasma NT-Pro BNP in patients with acute ischemic stroke and investigate whether the plasma NT- pro BNP level can be a useful bio marker to differentiate cardio embolic (CE) stroke from non-cardio embolic (NCE) stroke or not.
STUDY DESIGN: In our analytic observational prospective study, 66 patients were enrolled within 24 hours of the onset of acute ischemic stroke and met inclusion and exclusion criteria.
METHODOLOGY: Plasma NT-pro BNP level was performed in each patient. Clinical observations were recorded on special performa designed for the study. They were classified in to four groups: Cardioembolic (CE), Large artery atherosclerosis (LAA), Small-vessel disease (SVD) and other subtypes according to TOAST classification. Study outcome was measured by applying appropriate statistical tests at the end of all patient enrolments.
RESULTS: Out of 66 patients, 21(31.81 %) were cardioembolic whereas 45 (68.18%) patients were in non-cardioembolic (NCE) group. The result showed that plasma NT pro BNP levels were significantly higher in CE group than NCE group (p value<0.001). The optimal cut off point for NT pro BNP levels to differentiate CE stroke from NCE stroke was > 594 pg./ml with 93.33% Specificity and 66.67% Sensitivity.
CONCLUSION: As plasma biomarker NT-pro BNP has a good sensitivity, specificity and accuracy for early identification of cardio embolic stroke.

Key words: Plasma biomarker, NT-pro BNP, Cardio embolic Stroke


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Utkarsh Patel
Articles by Mahendra Thakre
Articles by Dnyaneshwar Asole
Articles by P.P. Ashok
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Patel U, Thakre M, Asole D, Ashok P, . The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. Int J Med Rev Case Rep. 2022; 6(21): 18-24. doi:10.5455/IJMRCR.172-1661420740

Web Style

Patel U, Thakre M, Asole D, Ashok P, . The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. https://www.mdpub.net/?mno=109086 [Access: April 05, 2024]. doi:10.5455/IJMRCR.172-1661420740

AMA (American Medical Association) Style

Patel U, Thakre M, Asole D, Ashok P, . The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. Int J Med Rev Case Rep. 2022; 6(21): 18-24. doi:10.5455/IJMRCR.172-1661420740


Vancouver/ICMJE Style

Patel U, Thakre M, Asole D, Ashok P, . The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. Int J Med Rev Case Rep. (2022), [cited April 05, 2024]; 6(21): 18-24. doi:10.5455/IJMRCR.172-1661420740


Harvard Style

Patel, U., Thakre, M., Asole, D., Ashok, P. & (2022) The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. Int J Med Rev Case Rep, 6 (21), 18-24. doi:10.5455/IJMRCR.172-1661420740


Turabian Style

Patel, Utkarsh, Mahendra Thakre, Dnyaneshwar Asole, P.P. Ashok, and . 2022. The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. International Journal of Medical Reviews and Case Reports, 6 (21), 18-24. doi:10.5455/IJMRCR.172-1661420740


Chicago Style

Patel, Utkarsh, Mahendra Thakre, Dnyaneshwar Asole, P.P. Ashok, and . "The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.." International Journal of Medical Reviews and Case Reports 6 (2022), 18-24. doi:10.5455/IJMRCR.172-1661420740


MLA (The Modern Language Association) Style

Patel, Utkarsh, Mahendra Thakre, Dnyaneshwar Asole, P.P. Ashok, and . "The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.." International Journal of Medical Reviews and Case Reports 6.21 (2022), 18-24. Print. doi:10.5455/IJMRCR.172-1661420740


APA (American Psychological Association) Style

Patel, U., Thakre, M., Asole, D., Ashok, P. & (2022) The Utility of Plasma N- Terminal Brain Natriuretic peptide (NT- Pro BNP) as a Biomarker to Differentiate Cardio embolic Stroke from Non-Cardio embolic Stroke.. International Journal of Medical Reviews and Case Reports, 6 (21), 18-24. doi:10.5455/IJMRCR.172-1661420740


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500